Curebase, founded with the mission to democratize access to clinical trials, aims to enable any patient, regardless of location, to participate in research from home and with their own doctors. The company offers a comprehensive suite of digital tools including eClinical software, virtual research sites, ePRO/eCOA for endpoint collection, and eConsent for a paperless, multimedia-supported consent process. Curebase focuses on decentralized clinical trials, making research more accessible and inclusive.
Notable figures affiliated with Curebase include industry-leading teams who trust their platform. The company has achieved significant milestones, including engaging 250,000 participants, signing 30,000 consents, and collecting 0.4 million data points. Curebase's innovative approach has had a substantial impact on the clinical trial landscape by enhancing patient engagement and streamlining trial processes through cutting-edge technology.
